ArticleAnnals of dermatology2026
Increased Risk of Psoriasis in Young Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Cohort Study.
Article in Annals of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is a newly defined condition linked to cardiometabolic risk. Its association with psoriasis remains unclear.
objectiveTo evaluate the association between MASLD and psoriasis risk in young adults in Korea.
methodsA retrospective cohort study was conducted using data from 6,400,590 adults aged 20-39 years in the Korean National Health Insurance Service. Participants were classified into seven study-defined, mutually exclusive SLD groups, and incident psoriasis was identified by International Statistical Classification of Diseases and Related Health Problems, 10th Revision codes. Cox proportional hazards models estimated hazard ratios (HRs).
resultsDuring a median follow-up of 9.1 years, 170,921 individuals developed psoriasis. MASLD was significantly associated with increased psoriasis risk (adjusted HR, 1.13). Risk estimates varied across the study-defined groups.
conclusionMASLD and related study-defined groups were associated with psoriasis risk in young adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.